Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for tho
- Posted on June 27, 2026
- By Business News Today
- 0 Views
- 1 min read
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for tho
Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like long-term adherence and physician conservatism. Biocon's Kiran Mazumdar-Shaw weighed in and urged caution, emphasizing diet and exercise as primary options for non-diabetic, non-obese individuals, citing potential long-term side effects of these metabolic-altering medications.
